Ayora, Miriam
Fraguas, David http://orcid.org/0000-0002-7931-2933
Abregú-Crespo, Renzo
Recio, Sandra
Blasco, María A. http://orcid.org/0000-0002-4211-233X
Moises, Ana
Derevyanko, Aksinya
Arango, Celso http://orcid.org/0000-0003-3382-4754
Díaz-Caneja, Covadonga M. http://orcid.org/0000-0001-8538-3175
Article History
Received: 27 July 2021
Revised: 12 March 2022
Accepted: 21 March 2022
First Online: 7 April 2022
Competing interests
: MA has held a Río Hortega grant from Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation). DF has been a consultant and/or has received fees from Angelini, Casen Recordati, Janssen, Lundbeck, and Otsuka. He has also received grant support from Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation) and from Fundación Alicia Koplowitz. RAC has received grant support from Instituto de Salud Carlos III. SR has no conflicts of interest. MB is founder and owns stock from Life Length, SL, a biotechnology company focussed on telomere length determinations for biomedical use. Aksinya Derevyanko has no conflicts of interest. CA has been a consultant to or has received honoraria or grants from Acadia, Abbot, AMGEN, AstraZeneca, Bristol-Myers Squibb, Caja Navarra, CIBERSAM, Dainippon Sumitomo Pharma, Fundación Alicia Koplowitz, Forum, Instituto de Salud Carlos III, Gedeon Richter, Janssen Cilag, Lundbeck, Merck, Ministerio de Ciencia e Innovación, Ministerio de Sanidad, Ministerio de Economía y Competitividad, Mutua Madrileña, Otsuka, Pfizer, Roche, Servier, Shire, Schering Plough, Sunovio and Takeda. CDC has received grant support from Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation) and honoraria from Exeltis and Angelini.